How does Bulkamid (polyacrylamide hydrogel) appear on a CT scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Bulkamid Appearance on CT Scan

Bulkamid (polyacrylamide hydrogel) appears as low-density material on CT scan and is difficult to visualize due to its water-like attenuation, making it challenging to differentiate from periurethral cysts or diverticula without additional imaging techniques.

CT Imaging Characteristics

  • Bulkamid demonstrates poor visualization on standard CT due to its composition as a hydrogel with inherent low density that mimics soft tissue or fluid 1, 2.

  • The ACR Appropriateness Criteria notes that CT has poor inherent soft-tissue resolution that makes visualization of synthetic urethral bulking agents challenging, though CT can demonstrate certain bulking agents when they are calcified 1.

  • Bulkamid specifically does not calcify and maintains its hydrogel properties, appearing as non-contrast-enhancing, low-attenuation material in the periurethral region 2.

Diagnostic Challenge and Solution

The primary clinical issue is that Bulkamid is nearly indistinguishable from periurethral cysts or diverticula on both CT and MRI due to its non-particulate nature and high tissue biocompatibility 2.

Recommended Imaging Protocol for Differentiation

When you need to distinguish Bulkamid from a true periurethral diverticulum, use a three-step CT protocol 2:

  1. Limited non-contrast CT pelvis (baseline to document absence of pre-existing high-density material)
  2. Voiding cystometrogram (VCMG) with contrast
  3. Repeat limited non-contrast CT pelvis immediately post-VCMG

  • The key differentiating feature: contrast will pass into a true urethral diverticulum during micturition and appear as high-density (bright) material, while Bulkamid will remain low-density and unchanged 2.

  • This CT-VCMG combination protocol is more effective than MRI for differentiating Bulkamid from periurethral pathology and prevents unnecessary surgical interventions 2.

Clinical Pitfalls

  • Do not rely on standard CT alone to evaluate periurethral bulking agents, as the poor soft-tissue contrast makes definitive identification unreliable 1.

  • MRI also fails to reliably differentiate Bulkamid from cysts or diverticula despite its superior soft-tissue resolution, because the hydrogel's signal characteristics mimic fluid collections 2.

  • Always obtain surgical history regarding bulking agent injections before planning intervention for presumed periurethral pathology, as misdiagnosis can lead to unnecessary procedures 2.

References

1
Guideline

acr appropriateness criteria® pelvic floor dysfunction in females.

Journal of the American College of Radiology, 2022

Related Questions

What is the best diagnostic imaging modality for evaluating a periurethral diverticulum?
In a patient with a TIRADS 3 thyroid nodule and a prior partial thyroidectomy, what is the appropriate next step in management?
What laboratory monitoring is recommended for a patient on cabergoline?
Which antidepressants can be safely combined with nortriptyline?
What are the contraindications for nicardipine?
What is the appropriate famotidine dosage for a 6‑year‑old child?
What is the recommended management for a patient with shoulder pain, marked range‑of‑motion limitation, an unremarkable MRI, and a downsloping acromion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.